Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial
David Sebag‐Montefiore(University of Leeds), Richard Stephens(Keele University), Lindsay C Thompson(MRC Clinical Trials Unit at UCL), Philip Quirke(University of Leeds), Audrey R. Holliday(MRC Clinical Trials Unit at UCL), Sahil Khanna(Mayo Clinic), Gareth Griffiths(NIHR Evaluation Trials and Studies Coordinating Centre), John R.T. Monson(Northwell Health), Richard Grieve(MRC Clinical Trials Unit at UCL), R. Steele(MRC Clinical Trials Unit at UCL)
Cited by 80
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Value of Mismatch Repair, <i>KRAS</i> , and <i>BRAF</i> Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
|Journal of Clinical Oncology|2011|678